Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ·Healthcare·Biotechnology
$13.25
+2.32%
Mkt Cap $261.88M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$48.20
Range $20.00 – $87.00
Implied Upside
+263.8%
Consensus $48.20 vs current $13.25
NASDAQ·Healthcare·Biotechnology
$13.25
+2.32%
Mkt Cap $261.88M
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$48.20
Range $20.00 – $87.00
+263.8%
Consensus $48.20 vs current $13.25